Roivant Sciences Ltd. · NASDAQ:ROIV

Manchester Keith S sold 1,381,762 Roivant Sciences Ltd. shares (Form 4)

Traded Nov 16 to Nov 17, 2026 · Filed Nov 18, 2026

From Nov 16 to Nov 17, 2026, Manchester Keith S (Director) sold 1,381,762 Roivant Sciences Ltd. shares at an average US$38.75 for US$53.5M, leaving 5,805,461 shares. Filed Nov 18, 2026 (Form 4).

Sold
1,381,762 shares
Price
US$38.75 average (US$38.24 to US$39.17)
Value
US$53.5M
Holding after
5,805,461 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 16, 2026Common SharesSale79,461US$39.1713,609,705Indirect
Nov 16, 2026Common SharesSale550,280US$39.171,042,200Indirect
Nov 16, 2026Common SharesSale18,927US$38.9913,590,778Indirect
Nov 16, 2026Common SharesSale131,073US$38.99911,127Indirect
Nov 17, 2026Common SharesOther2,635,1695,806,259Indirect
Nov 17, 2026Common SharesOther15,96913,574,809Indirect
Nov 17, 2026Common SharesOther385,620525,507Indirect
Nov 17, 2026Common SharesSale75,716US$38.2413,499,093Indirect
Nov 17, 2026Common SharesSale525,507US$38.240Indirect
Nov 17, 2026Common SharesSale798US$38.245,805,461Indirect

Source

Download original · View original at SEC

Related